Amgen (AMGN) PT Raised to $430 at RBC Capital

October 8, 2026 8:26 AM

RBC Capital analyst Luca Issi raised the price target on Amgen (NASDAQ: AMGN) to $430.00 (from $400.00) while maintaining a Outperform rating.

No results found